4//SEC Filing
Barton Russell 4
Accession 0001628280-26-001897
CIK 0001576885other
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 6:52 PM ET
Size
5.5 KB
Accession
0001628280-26-001897
Insider Transaction Report
Form 4
Barton Russell
Chief Operating Officer
Transactions
- Sale
Common Stock
[F1][F2]2026-01-08$1.86/sh−3,530$6,562→ 123,269 total
Footnotes (2)
- [F1]Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 25, 2025.
- [F2]The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.8000 to $1.9500. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Derek Meisner, Attorney-in-Fact|2026-01-12
Documents
Issuer
Acumen Pharmaceuticals, Inc.
CIK 0001576885
Entity typeother
Related Parties
1- filerCIK 0001867418
Filing Metadata
- Form type
- 4
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 6:52 PM ET
- Size
- 5.5 KB